← back to search

Gauri Shetye

University of Illinois Chicago · US
Area of research
Infectious Diseases · Pharmacology
Research interest
Research interests include Chemistry, Stereochemistry, Antimycobacterial, Combinatorial chemistry, Tuberculosis, and Mycobacterium tuberculosis.
h-index
citations
442
works
17
NIH funding
primary concept
email

Recent publications

Exploration of quinoxaline triazoles as antimycobacterial agents: design, synthesis and biological evaluation
Bioorganic & Medicinal Chemistry Letters 2025cited by 3position: middledoi
Selectivity of the Time-Dependent <i>M. tuberculosis</i> LeuRS Inhibitor Ganfeborole Is Driven by Target Vulnerability
ACS Chemical Biology 2025cited by 2position: middledoi
Design, synthesis and biological evaluation of novel pyrido-[2,3-d]-pyrimidin-2-amine analogues as antimycobacterial agents
Journal of Molecular Structure 2024cited by 7position: middledoi
Discovery of New Cyclic Lipodepsipeptide Orfamide N via Partnership with Middle School Students from the Boys and Girls Club
ACS Omega 2024cited by 3position: middledoi
Design, synthesis and biological evaluation of phenanthridine amide and 1,2,3-triazole analogues against <i>Mycobacterium tuberculosis</i>
RSC Medicinal Chemistry 2023cited by 6position: middledoi
Identification of the inhibitory mechanism of ecumicin and rufomycin 4-7 on the proteolytic activity of Mycobacterium tuberculosis ClpC1/ClpP1/ClpP2 complex
Tuberculosis 2022cited by 12position: middledoi
Targeted Antitubercular Peptide Nanocarriers Prepared by Flash NanoPrecipitation with Hydrophobic Ion Pairing
Advanced Materials Technologies 2022cited by 9position: middledoi
Synthesis, antimycobacterial, cytotoxicity, anti‐inflammatory, <i>in silico</i> studies and molecular dynamics of pyrazole‐embedded thiazolidin‐4‐one hybrids
Archiv der Pharmazie 2022cited by 8position: middledoi
Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis
Toxicology in Vitro 2021cited by 32position: middledoi
Rufomycins or Ilamycins: Naming Clarifications and Definitive Structural Assignments
Journal of Natural Products 2021cited by 32position: middledoi
<i>In Vitro</i>Profiling of Antitubercular Compounds by Rapid, Efficient, and Nondestructive Assays Using Autoluminescent Mycobacterium tuberculosis
Antimicrobial Agents and Chemotherapy 2021cited by 24position: firstdoi
Quinoline‐Proline, Triazole Hybrids: Design, Synthesis, Antituberculosis, Molecular Docking, and ADMET Studies
Journal of Heterocyclic Chemistry 2021cited by 10position: middledoi
Hydride-induced Meisenheimer complex formation reflects activity of nitro aromatic anti-tuberculosis compounds
RSC Medicinal Chemistry 2021cited by 9position: middledoi
New tuberculosis drug targets, their inhibitors, and potential therapeutic impact
Translational research 2020cited by 171position: firstdoi
Antimycobacterial Rufomycin Analogues from <i>Streptomyces atratus</i> Strain MJM3502
Journal of Natural Products 2020cited by 50position: middledoi
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors
European Journal of Medicinal Chemistry 2020cited by 31position: middledoi
Antimicrobial Lavandulylated Flavonoids from a Sponge-Derived Streptomyces sp. G248 in East Vietnam Sea
Marine Drugs 2019cited by 33position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Scott G. Franzblau · University of Illinois Chicago15 papers (2020–2025)Sang‐Hyun Cho · University of Illinois Chicago8 papers (2019–2024) · 5 papers (2021–2025)Rui Ma · Central China Normal University4 papers (2019–2023) · 4 papers (2021–2025) · 4 papers (2021–2025) · 3 papers (2021–2025)Hyun Lee · University of Illinois Chicago3 papers (2020–2022)Rui Ma · University of Illinois Chicago3 papers (2021–2024) · 3 papers (2023–2025) · 3 papers (2020–2022) · 3 papers (2021–2023)Shao‐Nong Chen · University of Illinois Chicago2 papers (2020–2021)Hanki Lee · University of Illinois Chicago2 papers (2020–2022) · 2 papers (2023–2024)James B. McAlpine · University of Illinois Chicago2 papers (2020–2021)Ying-Yu Jin · Harbin Medical University2 papers (2020–2021)Bin Zhou · University of Illinois Chicago2 papers (2020–2021)Jinhua Cheng · Zhengzhou University2 papers (2020–2021)Guido F. Pauli · Albany College of Pharmacy and Health Sciences2 papers (2020–2021)